BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Saketkoo LA, Russell AM, Jensen K, Mandizha J, Tavee J, Newton J, Rivera F, Howie M, Reese R, Goodman M, Hart P, Strookappe B, De Vries J, Rosenbach M, Scholand MB, Lammi MR, Elfferich M, Lower E, Baughman RP, Sweiss N, Judson MA, Drent M. Health-Related Quality of Life (HRQoL) in Sarcoidosis: Diagnosis, Management, and Health Outcomes. Diagnostics (Basel) 2021;11:1089. [PMID: 34203584 DOI: 10.3390/diagnostics11061089] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Obi ON, Saketkoo LA, Russell AM, Baughman RP. Sarcoidosis: Updates on therapeutic drug trials and novel treatment approaches. Front Med (Lausanne) 2022;9:991783. [PMID: 36314034 DOI: 10.3389/fmed.2022.991783] [Reference Citation Analysis]
2 Hilker C, Weis J, Ziehfreund S, Arkema EV, Biedermann T, Zink A. “The chameleon among diseases” - An explorative view of sarcoidosis and identification of the consequences for affected patients and relatives using qualitative interviews.. [DOI: 10.21203/rs.3.rs-1977181/v1] [Reference Citation Analysis]
3 Sugizaki CSA, Rodrigues HCN, Ivo JFM, Freitas ATVS, Stringhini MLF, Paiva SAR, Minicucci MF, Peixoto MRG, Costa NA. The relationship between grip strength with health-related quality of life and mortality in hemodialysis patients. Nutrire 2022;47:21. [DOI: 10.1186/s41110-022-00171-x] [Reference Citation Analysis]
4 Speranskaia A. Radiation Patterns of Modern Sarcoidosis (Alphabet). Sarcoidosis - New Perspectives 2022. [DOI: 10.5772/intechopen.99822] [Reference Citation Analysis]
5 Drent M, Jessurun NT, Wijnen PA, Bekers O, Bast A. Drug-induced comorbidities in patients with sarcoidosis. Curr Opin Pulm Med 2022. [PMID: 35855576 DOI: 10.1097/MCP.0000000000000889] [Reference Citation Analysis]
6 Saketkoo LA, Obi ON, Patterson KC, Russell AM. Ageing with Interstitial lung disease: preserving health and well being. Curr Opin Pulm Med 2022;28:321-36. [PMID: 35749798 DOI: 10.1097/MCP.0000000000000880] [Reference Citation Analysis]
7 Redl A, Stary G. Kutane Sarkoidose – eine granulomatöse Modellerkrankung. hautnah 2022;21:105-116. [DOI: 10.1007/s12326-022-00502-9] [Reference Citation Analysis]
8 Kahlmann V, Patel DC, Marts LT, Wijsenbeek MS. Non-organ-specific manifestations of sarcoidosis. Sarcoidosis 2022. [DOI: 10.1183/2312508x.10032320] [Reference Citation Analysis]
9 Tully T, Judson MA, Patel AS, Birring SS. Quality-of-life assessment in patients with sarcoidosis. Sarcoidosis 2022. [DOI: 10.1183/2312508x.10033720] [Reference Citation Analysis]
10 Murphy C, Marcoval J, Mañá J, Rosenbach M. Cutaneous sarcoidosis. Sarcoidosis 2022. [DOI: 10.1183/2312508x.10032120] [Reference Citation Analysis]
11 Gavrilova N, Starshinova A, Zinchenko Y, Kudlay D, Shapkina V, Malkova A, Belyaeva E, Pavlova M, Yablonskiy P, Shoenfeld Y. Small Fiber Neuropathy in Sarcoidosis. Pathophysiology 2021;28:544-50. [DOI: 10.3390/pathophysiology28040035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]